Cancer care costs in the U.S. exceed $250 billion annually, with nearly 2 million new diagnoses each year — yet many patients start their journey without guidance or support.
In this conversation, a16z’s Vineeta Agarwala and Jay Rughani sit down with Thyme Care’s Robin Shah, Bobby Green, MD, and Brad Diephuis, MD to explore how the oncology system can be redesigned around the patient. They discuss the breakdowns in traditional care, the power of navigation paired with value-based models to align incentives, and how AI can amplify clinical capacity. The episode highlights how Thyme Care’s approach — now serving more than 83,000 active patients — offers a scalable model for patient-centered oncology.